Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AVBP
Stock Latest News
Ratings
ArriVent BioPharma, Inc.: Promising Future with Strong Financials and Key Data Releases Justifying Buy Rating
1d ago
AVBP
Premium
The Fly
Cooperman’s Omega bought Atlas Energy and ArriVent in Q2
3d ago
ET
APO
Premium
The Fly
ArriVent Biopharma price target raised to $42 from $40 at H.C. Wainwright
5d ago
AVBP
Premium
The Fly
ArriVent Biopharma price target lowered to $33 from $40 at Citi
5d ago
AVBP
Premium
Company Announcements
ArriVent BioPharma Advances Cancer Therapeutics Pipeline
5d ago
AVBP
Premium
Ratings
Positive Growth Trajectory and Buy Rating for ArriVent BioPharma, Inc. Driven by Promising Clinical Data and Strategic Development
5d ago
AVBP
Premium
The Fly
ArriVent Biopharma reports Q2 EPS (90c), consensus (71c)
6d ago
AVBP
Premium
The Fly
ArriVent Biopharma sees cash runway into mid-2027
6d ago
AVBP
Premium
Pre-Earnings
ArriVent BioPharma, Inc. (AVBP) Q2 Earnings Cheat Sheet
6d ago
AVBP
Premium
Ratings
ArriVent BioPharma Positioned for Success: Buy Rating on Strong Phase 3 Prospects and Financial Health
6d ago
AVBP
Premium
The Fly
ArriVent Biopharma management to meet with Oppenheimer
20d ago
AVBP
Premium
Ratings
ArriVent BioPharma’s Promising Clinical Trials and Strategic Plans Drive Buy Rating with $40 Price Target
26d ago
AVBP
Premium
Ratings
Buy Rating for ArriVent BioPharma: Promising Potential of Lead Candidate and Solid Financial Position
27d ago
AVBP
Premium
Company Announcements
ArriVent BioPharma Announces Phase 3 Trial Data Release
27d ago
8K
AVBP
Premium
The Fly
ArriVent Biopharma announces data from its FURVENT Phase 3 study
27d ago
AVBP
Premium
Ratings
ArriVent BioPharma, Inc.: Promising Developments and Strategic Advancements Drive Buy Rating
1M ago
AVBP
Premium
The Fly
ArriVent Biopharma resumed with a Buy at Goldman Sachs
1M ago
AVBP
Premium
Company Announcements
ArriVent BioPharma Announces $75 Million Public Offering
2M ago
8K
AVBP
Premium
The Fly
ArriVent Biopharma 2.5M share Spot Secondary priced at $19.50
2M ago
AVBP
Premium
The Fly
ArriVent Biopharma announces $75M common stock, warrants offering
2M ago
AVBP
Premium
The Fly
ArriVent Biopharma initiated with a Buy at Clear Street
2M ago
AVBP
Premium
The Fly
ArriVent Biopharma price target raised to $44 from $39 at Oppenheimer
2M ago
AVBP
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
